Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection

Journal of Clinical Virology

Volumn 34, Issue 1, 2005, Pages 63-70

  Raghuraman, Sukanya ^a   Abraham, Priya ^a   Daniel, Hubert Darius ^a   Ramakrishna, B S ^a   Sridharan, Gopalan ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Fas; HCV infection; India; TNF alpha

Indexed keywords

ALANINE AMINOTRANSFERASE; FAS ANTIGEN; FAS LIGAND; MARKER; TETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA; WATER;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CELL ASSAY; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOSURVEILLANCE; LIVER BIOPSY; MALE; MEDICAL RECORD; PATIENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ASSAY; VIRUS INFECTION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD95; BIOLOGICAL MARKERS; CELL DEATH; FAS LIGAND PROTEIN; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS;

EID: 23744476315     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2005.01.009     Document Type: Article

References (27)

1. C. Azzari, M. Resti, M. Moriondo, R. Ferrari, P. Lionetti, and A. Vierucci Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection Blood 96 2000 2045 2048
2. J. Cheng, T. Zhou, C. Liu, J.P. Shapiro, M.J. Brauer, M.C. Kiefer, P.J. Barr, and J.D. Mountz Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule Science 263 1994 1759 1762
3. O. Disson, D. Haouzi, S. Desagher, K. Loesch, M. Hahne, E.J. Kremer, C. Jacquet, S.M. Lemon, U. Hibner, and H. Lerat Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein Gastroenterology 126 2004 859 872
4. M.E. Eyster Effect of HIV infection on hepatitis C Viral Hep Rev 4 1998 189 206
5. C. Gremion, B. Grabscheid, B. Wolk, D. Moradpour, J. Reichen, W. Pichler, A. Cerny, and Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction J Virol 78 2004 2152 2157
6. N. Hayashi, and E. Mita Fas system and apoptosis in viral hepatitis J Gastroenterol Hepatol 12 1997 S223 S226
7. S. Iio, N. Hayashi, E. Mita, K. Ueda, K. Mochizuki, N. Hiramatsu, T. Kanto, Y. Sasaki, A. Kasahara, and M. Hori Serum levels of soluble Fas antigen in chronic hepatitis C patients J Hepatol 29 1998 517 523
8. S. Jodo, S. Kobayashi, Y. Nakajima, T. Matsunaga, N. Nakayama, N. Ogura, N. Kayagaki, K. Okumura, and T. Koike Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma Clin Exp Immunol 112 1998 166 171
9. P.D. Katsikis, E.S. Wunderlich, C.A. Smith, and L.A. Herzenberg Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals J Exp Med 181 1995 2029 2036
10. N. Kobayashi, Y. Hamamoto, N. Yamamoto, A. Ishii, M. Yonehara, and S. Yonehara Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication Proc Natl Acad Sci USA 87 1990 9620 9624
11. J.Y. Lau, X. Xie, M.M. Lai, and P.C. Wu Apoptosis and viral hepatitis Semin Liver Dis 18 1998 169 176
12. K. Machida, K. Tsukiyama-Kohara, E. Seike, S. Tone, F. Shibasaki, M. Shimizu, H. Takahashi, Y. Hayashi, N. Funata, C. Taya, H. Yonekawa, and M. Kohara Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins J Biol Chem 276 2001 12140 12146
13. M. Matsumoto, T.Y. Hsieh, N. Zhu, T. VanArsdale, S.B. Hwang, K.S. Jeng, A.E. Gorbalenya, S.Y. Lo, J.H. Ou, C.F. Ware, and M.M. Lai Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor J Virol 71 1997 1301 1309
14. D.R. Nelson, C.G. Marousis, G.L. Davis, C.M. Rice, J. Wong, M. Houghton, and J.Y. Lau The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C J Immunol 158 1997 1473 1481
15. D.R. Nelson, H.L. Lim, C.G. Marousis, J.W. Fang, G.L. Davis, L. Shen, M.S. Urdea, J.A. Kolberg, and J.Y. Lau Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection Dig Dis Sci 42 1997 2487 2494
16. J. Ogasawara, R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata Lethal effect of the anti-Fas antibody in mice Nature 364 1993 806 809
17. K. Ohkawa, N. Hiramatsu, K. Mochizuki, E. Mita, S. Iio, H. Yoshihara, M. Kato, M. Masuzawa, A. Kasahara, Y. Sasaki, M. Hori, and N. Hayashi Significance of serum soluble Fas antigen level in chronic hepatitis C patients treated with interferon: relationship to the therapeutic response J Gastroenterol Hepatol 16 2001 1009 1014
18. S. Radhakrishnan, P. Abraham, S. Raghuraman, G.T. John, P.P. Thomas, C.K. Jacob, and G. Sridharan Role of molecular techniques in the detection of HBV DNA & HCV RNA among renal transplant recipients in India Indian J Med Res 111 2000 204 211
19. B. Rehermann Immunopathogenesis of hepatitis C T.J. Liang JH. Hoofnagle Hepatitis C - biomedical research reports 2000 Academic Press 147 168
20. P. Schneider, N. Holler, J.L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity J Exp Med 187 1998 1205 1213
21. M. Seishima, M. Takemura, K. Saito, K. Ando, and A. Noma Increased serum soluble Fas (sFas) concentrations in HCV-positive patients with liver cirrhosis J Hepatol 27 1997 424 425
22. E.M. Sloand, N.S. Young, P. Kumar, F.F. Weichold, T. Sato, and J.P. Maciejewski Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication Blood 89 1997 1357 1363
23. N. Taya, Y. Torimoto, M. Shindo, K. Hirai, C. Hasebe, and Y. Kohgo Fas-mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C Br J Haematol 110 2000 89 97
24. J.G. Teodoro, and P.E. Branton Regulation of apoptosis by viral gene products J Virol 71 1997 1739 1746
25. R. Thimme, D. Oldach, K.M. Chang, C. Steiger, S.C. Ray, and F.V. Chisari Determinants of viral clearance and persistence during acute hepatitis C virus infection J Exp Med 194 2001 1395 1406
26. D.K. Wong, D.D. Dudley, P.B. Dohrenwend, G.M. Lauer, R.T. Chung, D.L. Thomas, and B.D. Walker Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV J Virol 75 2001 1229 1235
27. E. Zuckerman, and T. Zuckerman Hepatitis C and B-cell lymphoma: Cause and effect Viral Hep Rev 6 2000 165 175